课题基金 / 基金详情

Proteomics of Staphylococcus aureus nasal carriage

Proteomics of Staphylococcus aureus nasal carriage
金黄色葡萄球菌鼻携带的蛋白质组学
批准号:
6531771
负责人:
ALEXANDER MICHAEL COLE
金额:
$15.26万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2004-03-31

项目摘要

项目成果

ALEXANDER MICHAEL COLE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The human nasal mucosa is an accessible and clinically important model for the study of microbial interactions with host defenses. Nasal carriage of Staphylococcus aureus (SA) is the most common clinical disorder of mucosal host defense but its molecular and cellular basis is not understood. The disorder is of increasing clinical importance because nosocomial infections are commonly spread by nasal carriers of methicillin-resistant SA and other SA strains increasingly resistant to antibiotics. Our evidence indicates that colonization may be due to impaired innate antimicrobial activity of nasal fluid. The current proposal aims to identify the underlying cause(s) of SA carriage by examining protein determinants of SA carrier airways colonization and comparing microbicidal components of SA carrier fluid to nasal fluids from donors that are not colonized with SA. We hypothesize that 1) noncarriers express antimicrobial (poly)peptide factors some of which are either lacking or defective in SA carrier fluid, 2) altered or deficient host defense factors in airways fluid contribute to the progressive colonization of SA in carriers, and 3) correcting the dysregulated components will restore the antimicrobial activity of SA carrier airway fluid against isolates of SA. To test these hypotheses, we will: 1) detect cationic (poly)peptides that are differentially expressed between nasal fluid from donors carrying SA and fluid from donors that are not colonized with SA utilizing a novel two-dimensional gel electrophoresis (2-DE) approach, 2) identify (poly)peptides that are differentially expressed between donors carrying SA and donors that are not colonized with SA, and 3) reconstitute the antimicrobial activity of SA carrier nasal fluid by replacing abnormal or missing (poly)peptides with intact counterparts purified from noncarrier fluid. Our proposed studies represent a novel approach to identify and link human airway disease biomarkers (cationic polypeptide antimicrobials) with their effects (SA nasal carriage). Together, these studies will for the first time characterize the host resistance factors for a common and increasingly important source of nosocomial infection, and will develop a neglected but very useful natural model for the study of the interactions of bacteria with an accessible mucosal surface.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Augmenting innate immunity to combat nasal carriage of Staphylococcus aureus
  • 批准号:
    9241954
  • 项目类别:
  • 资助金额:
    $21.9万
  • 财政年份:
    2016
  • 负责人:
    ALEXANDER MICHAEL COLE
  • 依托单位:
Augmenting innate immunity to combat nasal carriage of Staphylococcus aureus
  • 批准号:
    9111552
  • 项目类别:
  • 资助金额:
    $18.25万
  • 财政年份:
    2016
  • 负责人:
    ALEXANDER MICHAEL COLE
  • 依托单位:
Development of nonhuman primate model of S. aureus nasal carriage
  • 批准号:
    8953176
  • 项目类别:
  • 资助金额:
    $26.14万
  • 财政年份:
    2015
  • 负责人:
    ALEXANDER MICHAEL COLE
  • 依托单位:
Aminoglycoside microbicides restore natural expression of anti-HIV-1 retrocyclins
  • 批准号:
    7935209
  • 项目类别:
  • 资助金额:
    $19.87万
  • 财政年份:
    2009
  • 负责人:
    ALEXANDER MICHAEL COLE
  • 依托单位:
海外基金